Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study.

To study the efficacy of alpha lipoic acid (ALA) in a group of patients with burning mouth syndrome (BMS). Sixty BMS patients, 30 treated with ALA (Thioderm) 800 mg day(-1) for 8 weeks and 30 patients on the same protocol with a placebo. The symptomatology was measured on a Visual Analogue Scale (VAS). Sixty patients (54 females and 6 males, mean age 64.37 +/- 11.61 years) were included. Thirty-nine patients completed the treatment (23 with ALA and 16 with a placebo). Reviews were carried out at 0, 1 and 2 months. No statistically significant differences were found in the average pre- and post-treatment values for pain with the VAS scores, obtained in the placebo (6.6 +/- 2.5 - 2.8 +/- 25 = 3.8 +/- 3.7) versus ALA (6.3 +/- 2.8 - 4.0 +/- 2.7 = 2.2 +/- 2.6). Only one patient pertaining to the group treated with ALA abandoned because of adverse gastrointestinal side effects. The results showed no significant differences between the two groups.
AuthorsP López-Jornet, F Camacho-Alonso, S Leon-Espinosa
JournalJournal of oral rehabilitation (J Oral Rehabil) Vol. 36 Issue 1 Pg. 52-7 (Jan 2009) ISSN: 1365-2842 [Electronic] England
PMID18976257 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Antioxidants
  • Thioctic Acid
  • Aged
  • Antioxidants (therapeutic use)
  • Burning Mouth Syndrome (drug therapy)
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pain Threshold (drug effects)
  • Thioctic Acid (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: